glp 1 and steroids New guidance on the use of GLP-1-based drugs in people with type diabetes (T1D), due to be published later this year, will address the safety optimal use of these medications Wellness hexagons Clinical review of how packes:2

glp 1 and steroids New guidance on the use of GLP-1-based drugs in people with type diabetes (T1D), due to be published later this year, will address the safety optimal use of these medications Wellness hexagons Clinical review of how packes:2

Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it - ScienceDirect

This unique property makes it attractive to people managing blood sugar and weight

Wellness hexagons

packes:2

Patient retention rates average 78% at six months, with most discontinuations due to cost rather than efficacy concerns